Myocardial protection with potassium-channel openers is as effective as St. Thomas' solution in the rabbit heart

Annals of Thoracic Surgery

Volumn 62, Issue 1, 1996, Pages 31-39

  Lawton, Jennifer S ^a   Sepic, Jerry D ^a   Allen, Cynthia T ^a   Hsia, Peng Wie ^a   Damiano Jr , Ralph J ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIKALIM; PINACIDIL; ST THOMAS HOSPITAL SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; PRIORITY JOURNAL; RABBIT;

EID: 0030200213     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00260-3     Document Type: Article

References (30)

1. + channels in cardiac muscle. Nature 1983;305:147-8.
2. 2. Nichols CG, Lederer WJ. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol 1991;261:H1675-86.
3. 3. Grover GJ. Protective effects of ATP-sensitive potassium channel openers in experimental myocardial ischemia. J Cardiovasc Pharmacol 1994;24:518-27.
4. 4. McPherson CD, Pierce GN, Cole WC. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation. Am J Physiol 1993;265:H1809-18.
5. 5. Sargent CA, Sleph PG, Dzwonczyk S, Normandin D, Antonaccio MJ, Grover GJ. Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075. J Cardiovasc Pharmacol 1993;22:564-70.
6. 6. Galinanes M, Shattock MJ, Hearse DJ. Effects of potassium channel modulation during global ischemia in isolated rat heart with and without cardioplegia. Cardiovasc Res 1992; 26:1063-8.
7. 7. D'Alonzo AJ, Darbenzio RB, Parham CS, Grover GJ. Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration. Cardiovasc Res 1992; 26:1046-53.
8. 8. Grover GJ, Sleph PG, Dzwonczyk S. Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs. J Cardiovasc Pharmacol 1990;16:853-64.
9. 9. Jerome SN, Akimitsu T, Gute DC, Korthuis RJ. Ischemic preconditioning attenuates capillary no-reflow induced by prolonged ischemia and reperfusion. Am J Physiol 1995;268: H2063-7.
10. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994;89: 1769-75.
11. 11. Katz AM. Physiology of the heart. 2nd ed. New York: Raven, 1992:438-9.
12. 12. Cohen NM, Lederer WJ, Nichols CG. Activation of ATP-sensitive potassium channels underlies contractile failure in single human cardiac myocytes during complete metabolic blockade. J Cardiovasc Electrophysiol 1992;3:56-63.
13. 13. Kleber AG, Oetliker H. Cellular aspects of early contractile failure in ischemia. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The heart and cardiovascular system. New York: Raven, 1992:1975-2020.
14. 14. Reimer KA, Jennings RB. Myocardial ischemia, hypoxia and infarction. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The heart and cardiovascular system. New York: Raven, 1992:1875-973.
15. 15. Cohen NM, Wise RM, Wechsler AS, Damiano RJ. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. J Thorac Cardiovasc Surg 1993;106:317-28.
16. 16. Maskal SL, Cohen NM, Hsia PW, Wechsler AW, Damiano RJ. Hyperpolarized cardiac arrest with a potassium-channel opener, aprikalim. J Thorac Cardiovasc Surg 1995;110:1083-95.
17. 17. Lawton JS, Harrington GC, Allen CT, Hsia P-W, Damiano RJ Jr. Myocardial protection with pinacidil cardioplegia in the blood-perfused heart. Ann Thorac Surg 1996;61:1680-8.
18. 18. Goto Y, Slinker BK, LeWinter MM. Decreased contractile efficiency and increased nonmechanical energy cost in hyperthyroid rabbit heart. Circ Res 1990;66:999-1011.
19. 19. Moon MR, DeAnda A, Daughters GT, Ingels NB, Miller DC. Experimental evaluation of different chordal preservation methods during mitral valve replacement. Ann Thorac Surg 1994;58:931-44.
20. 20. Shintani H, Glantz SA. Effect of disrupting the mitral apparatus on left ventricular function in dogs. Circulation 1993; 87:2001-15.
21. 21. Fremes SE, Zhang J, Furukawa RD, Mickle DA, Weisel RD. Adenosine pretreatment for prolonged cardiac storage. J Thorac Cardiovasc Surg 1995;110:293-301.
22. 22. Stark PA. Introduction to numerical methods. New York: Macmillan, 1970:196-8.
23. 23. Kirvaitis RJ, Krukenkamp IB, Bukhari EA, Gaudette GR, Miyatake T, Levitsky S. Pinacidil-induced hyperpolarized cold blood cardioplegia: a novel myoprotective strategy. Surg Forum 1995;46:224-6.
24. + channels mediate postcardioplegia coronary hyperemia. J Thorac Cardiovasc Surg 1995;110:1073-82.
25. 25. Ahnfelt-Ronne I. Pinacidil pre-clinical investigation: basic mechanisms and mode of action. Drugs 1988;36(Suppl 7): 4-9.
26. 26. Maskal SL, Fields CE, Cohen NM, Damiano RJ. Persistent electrical activity during hyperpolarized cardiac arrest does not affect post ischemic myocardial recovery. Surg Forum 1995;46:222-4.
27. 27. Klocke FJ, Braunwald E, Ross J. Oxygen cost of electrical activity of the heart. Circ Res 1966;18:357-65.
28. 28. Grover GJ, Dzwonczyk S, Sleph PG. Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891. Eur J Pharmacol 1990;191:11-8.
29. 29. Barner HB. Blood cardioplegia: a review and comparison with crystalloid cardioplegia. Ann Thorac Surg 1991;52: 1354-67.
30. 30. Galinanes M, Hearse DJ. Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection. Cardioscience 1990;2:127-43.